• / Free eNewsletters & Magazine
  • / My Account
Home>Proteostatis's IPO prices well below expected range, but sells more shares

Proteostatis's IPO prices well below expected range, but sells more shares

3party Content

Thu, 11 Feb 2016

Proteostasis Therapeutics Inc. said Thursday its initial public offering of 6.25 million shares priced at $8 a share, well below the expected per-share range of $12 to $14. The amount of shares the biopharmaceutical company sold was above the 3.85 million shares they had expected to sell, according
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.